Literature DB >> 26697184

Vasovagal response secondary to permanent contraception device in pulmonary arterial hypertension.

Ali Ataya1, Jessica Cope2, Hassan Alnuaimat1.   

Abstract

Adequate contraception is an essential component of managing pulmonary hypertension in women of childbearing age. Intrauterine devices are a popular contraceptive choice for many women but are associated with a risk of vagal response upon placement in certain patients with pulmonary hypertension, which may not be well tolerated. More recently, newer permanent contraception devices have emerged in the market, such as the Essure. We describe the first case, to our knowledge, of vagal-associated response due to an Essure device placement.

Entities:  

Year:  2015        PMID: 26697184      PMCID: PMC4671751          DOI: 10.1086/683691

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  3 in total

Review 1.  Pregnancy and pulmonary hypertension.

Authors:  Petronella G Pieper; Heleen Lameijer; Elke S Hoendermis
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2014-03-14       Impact factor: 5.237

2.  Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study.

Authors:  John F Kerin; Jay M Cooper; Thomas Price; Bruno J Van Herendael; Enrique Cayuela-Font; Daniel Cher; Charles S Carignan
Journal:  Hum Reprod       Date:  2003-06       Impact factor: 6.918

Review 3.  Birth control and pregnancy management in pulmonary hypertension.

Authors:  Karen M Olsson; Xavier Jais
Journal:  Semin Respir Crit Care Med       Date:  2013-09-13       Impact factor: 3.119

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.